Table 4.
Antimicrobial resistance of gram-positive bacteria.
| P | OX | CZ | CXM | E | CL | GM | LVX | RA | LNZ | VA | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CoNS | |||||||||||
| 2006–2010 | 34 | 16 | 15 | 4 | 26 | 8 | 5 | 2 | 0 | 0 | 0 |
| (n = 41) | 82.9 | 39.0 | 36.6 | 9.8 | 63.4 | 19.5 | 12.2 | 4.9 | 0 | 0 | 0 |
| 2011–2015 | 22 | 34 | 11 | 12 | 28 | 17 | 15 | 12 | 6 | 0 | 0 |
| (n = 55) | 40.0 | 61.8 | 20.0 | 21.8 | 50.9 | 30.9 | 27.3 | 21.8 | 10.9 | 0 | 0 |
| Total | 56 | 50 | 26 | 16 | 54 | 25 | 20 | 14 | 6 | 0 | 0 |
| (n = 96) | 58.3 | 52.1 | 27.1 | 16.7 | 56.3 | 26.0 | 20.8 | 14.6 | 6.3 | 0 | 0 |
| P | 0.01▲ | 0.03▲ | 0.07 | 0.12 | 0.22 | 0.21 | 0.07 | 0.02▲ | 0.08 | – | – |
| Staphylococcus aureus | |||||||||||
| 2006–2010 | 12 | 5 | 2 | 2 | 10 | 8 | 4 | 1 | 0 | 0 | 0 |
| (n =16) | 75.0 | 31.3 | 12.5 | 12.5 | 62.5 | 50.0 | 25.0 | 6.3 | 0 | 0 | 0 |
| 2011–2015 | 6 | 7 | 3 | 3 | 10 | 12 | 10 | 9 | 3 | 0 | 0 |
| (n = 20) | 30.0 | 35.0 | 15.0 | 15.0 | 50.0 | 60.0 | 50.0 | 45.0 | 15.0 | 0 | 0 |
| Total | 18 | 12 | 5 | 5 | 20 | 20 | 14 | 10 | 3 | 0 | 0 |
| (n = 36) | 50.0 | 33.3 | 13.9 | 13.9 | 55.6 | 55.6 | 38.9 | 27.8 | 8.3 | 0 | 0 |
| P | 0.01▲ | 0.82 | 0.83 | 0.83 | 0.46 | 0.55 | 0.13 | 0.01▲ | 0.11 | – | – |
P, penicillin; OX, oxacillin; CZ, cefazolin; CXM, cefuroxime; E, erythromycin; CL, clindamycin; GM, gentamicin; LVX, levofloxacin; RA, rifampicin; LNZ, linezolid; VA, vancomycin.
▲ Significant at P < 0.05.